Restricted accessResearch articleFirst published online 1997-6
Intravital Microscope Studies on the Effects of Neurokinin Agonists and Calcitonin Gene-Related Peptide on Dural Vessel Diameter in the Anaesthetized Rat
This study describes a novel intravital microscope technique for direct measurement of dural blood vessel diameter through a closed cranial window in anaesthetized rats. This technique avoids removal of the skull which can lead to problems o altered vessel reactivity and brain swelling that are encountered with open cranial window techniques. Substance P and calcitonin gene-related (CGRP) evoked increases in dura vessel diameter, which were abolished by the NK1 receptor antagonist, RP67580 and the CGRP receptor antagonist, human-CGRP(8–31) respectively. Neurokinin A produced increases in dural vessel diameter which were unaffected by the NK2 receptor antagonist SR 48968 but were blocked by RP67580, suggesting that neurokinin A can act through NK1 receptors to produce dural vasodilation in rats. The NK3 receptor agonist, senktide, had no effects on dural vessel diameter. All drugs were administered intravenously. In humans, vasodilation within the meningeal vasculature has been implicated in the pathogenesis of migraine, the present experiments indicate that substance P or neurokinin A (both acting through NK1 receptors) or CGRP may be responsible.
MoskowitzMA.Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine.
Trends Pharmacol Sci1992;
13:
307–11
2.
UddmanREdvinssonL.Neuropeptides in the cerebral circulation.
Cerebrovasc Brain Metab Rev1989;
1:
230–52
3.
GoadsbyPJEdvinssonLEkmanR.Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.
Ann Neurol1988;
23:
193–6
4.
JansenIUddmanREkmanROlesenJOttossonAEdvinssonL.Distribution and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries.
Peptides1992;
13:
527–36
5.
BeattieDT.StubbsCMConnorHEFeniukW.Neurokininduced changes in pial artery diameter in the anaesthetized guinea-pig.
Br J Pharmacol1993;
108:
146–9
6.
JansenIAlafaciCMcCullochJUddmanREdvinssonL.Tachykinins (substance P, neurokinin A, Neuropeptide K and Neurokinin B) in the cerebral circulation. vasomotor responses in vitro and in situ.
J Cereb Blood Flow Metab1991;
11:
67–75
7.
EscottKJConnorHEBrainSDBeattieDT.The involvement of calcitonin gene-related peptide (CGRP) and substance in feline pial artery diameter responses evoked by capsaicin.
Neuropeptides1995;
29:
129–35
8.
KurosawaMMesslingerKPawlakMSchmidtRF.Increase of meningeal blood flow after electrical stimulation of r t dura mater encephali: mediation by calcitonin gene-related puptide.
Br J Pharmacol1995;
114:
1397–2
9.
LeeCCampbellNJWilliamsBJIversenLL.Multiple tachykinin binding in peripheral tissues and in brain.
Eurol Pharmacol1986;
130:
209–17
10.
CascieriMAHuangR-RCFongTMCheungAHSadowskiSBerEStraderCD.Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
Mol Pharmacol1992;
41:
1096–99
11.
GarretCCarruetteAFardinVMoussaouiSPeyronelJBlanchardJLaduronPM.Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
Proc Natl Acad Soc USA1991;
88:
10208–12
12.
LongmoreJSwainCJHillRG.Neurokinin receptors.
Drug News Perspect1995;
8:
5–23
13.
AdvenierCRouissiNNguyenQTEmonds-AltXBreliereJNeliatGNeurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist.
Biochem Biophys Res Commun1992;
184:
1418–24
14.
ChibaTYamaguchiAToshiyukiYNakamuraAMorishitaTInuiTCalcitonin gene-related peptide receptor antagonist human CGRP-(8-37).
Am J Physiol1989;
256:
E331–5
15.
WilliamsonDJHargreavesRJHillRGShepheardSL.Direct measurement of dural blood vessel diameter in the rat using intravital microscopy.
Br J Pharmacol1996;
117:
271P
Delay-GoyetPSatohH.LundbergJM.Relative involvement of substance P and CGRP mechanisms in antidromic vasodilation in the rat skin.
Acta Physiol Scand1992;
146:
537–8
18.
EdvinssonLOlesenIJKingmanTAMcCullochJUddmanR.Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP.
Cephalalgia1995;
15:
373–83
19.
MesslingerKHaneschUBaumgartelMTrostBSchmidtRF.Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity.
Anat Embryol1993;
188:
219–37
20.
EdvinssonLHaraHUddmanR.Retrograde tracing of nerve fibres to the rat middle cerebral artery with true blue: colocalization with different peptides.
J Cereb Blood Flow Metab1989;
9:
212–8
21.
LeeYKawaiYShiosakaSTakamiKKiyamaHHillyardCJCoexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis.
Brain Res1985;
330:
194–6
22.
UddmanRHaraHEdvinssonL.Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunohistochemistry.
J Auton Nerv Syst1989;
26:
69–75
23.
GoadsbyPJEdvinssonLEkmanR.Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.
Ann Neurol1990;
28:
183–7
24.
RayBSWolffHG.Experimental studies on headache: pain sensitive structures of the head and their significance in headache.
Arch Surg1940;
41:
813–56
25.
PenfieldWMcNaughtonF.Dural headache and innervation of the dura mater.
Arch Neurol Psychiatry1940;
44:
43–75
26.
GallaiVSarchielliPFranceschiniMCodiniMGliotiGTrequattriniAPalumboR.Vasoactive peptide levels in the plasma on young migraine patients with and without aura assessed both interictally and ictally.
Cephalalgia1995;
15:
384–90
27.
DienerHC
for the RPR100893-201 migraine study group.
Substance-P antagonist RPR100893-201 is not effective in human migraine attacks.
6th International Headache Research Seminar,
17-19 November 1995,
Copenhagen, Denmark
28.
GoldsteinD.Clinical trials of tachykinin antagonists.
IBC Conference on Tachykinins and their Antagonists,
10-11 October 1996,
London, UK
29.
EdvinssonL.Innervation and effects of dilatory neuropeptides on cerebral vessels.
Blood vessels.
1991;
28:
35–45
